Medication info
Dementia Tablets (Memantine Hydrochloride)

Dementia Tablets (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Korea Union Pharm (Co., Ltd.)
Appearance
White oval film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200501472 · Notified 2005.04.18 · Insurance code 665500570

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer's dementia, and only when a caregiver is able to periodically check that the patient is taking the medication. Diagnosis should be made according to currently accepted guidelines. The clinical benefit of this medicine and the patient's tolerability of treatment should be periodically reassessed. This medicine may be taken with or without food. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows, until the maintenance dose is reached. Week 1 (Days 1-7): Administer 5mg daily for 7 days. Week 2 (Days 8-14): Administer 10mg daily (5mg twice daily) for 7 days. Week 3 (Days 15-21): Administer 15mg daily (10mg in the morning and 5mg in the evening) for 7 days. From Week 4: Administer 20mg daily (10mg twice daily). Maintenance dose: The recommended maintenance dose is 20mg daily (10mg twice daily). Elderly: Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20mg daily (10mg twice daily). Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-50 mL/min), the daily dose should be reduced to 10mg. If well tolerated, the dose may be increased to 20mg daily according to the standard dose-escalation regimen after at least 7 days of treatment. In patients with severe renal impairment (creatinine clearance 5-30 mL/min), the daily dose should be reduced to 10mg. Patients with hepatic impairment: No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Ingredients

Manufacturer
Korea Union Pharm (Co., Ltd.)

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease.

How to take

Adult dose

Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer's dementia, and only when a caregiver is able to periodically check that the patient is taking the medication. Diagnosis should be made according to currently accepted guidelines. The clinical benefit of this medicine and the patient's tolerability of treatment should be periodically reassessed. This medicine may be taken with or without food. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows, until the maintenance dose is reached. Week 1 (Days 1-7): Administer 5mg daily for 7 days. Week 2 (Days 8-14): Administer 10mg daily (5mg twice daily) for 7 days. Week 3 (Days 15-21): Administer 15mg daily (10mg in the morning and 5mg in the evening) for 7 days. From Week 4: Administer 20mg daily (10mg twice daily). Maintenance dose: The recommended maintenance dose is 20mg daily (10mg twice daily). Elderly: Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20mg daily (10mg twice daily). Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-50 mL/min), the daily dose should be reduced to 10mg. If well tolerated, the dose may be increased to 20mg daily according to the standard dose-escalation regimen after at least 7 days of treatment. In patients with severe renal impairment (creatinine clearance 5-30 mL/min), the daily dose should be reduced to 10mg. Patients with hepatic impairment: No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Precautions

This medication should not be administered to certain patients. First, individuals allergic to any of the components of this medication should not take it. Second, patients with severely impaired liver function or severely diminished kidney function should not use this medication. Third, individuals with lactose intolerance or specific genetic metabolic disorders should also not use this medication. Furthermore, special caution is needed for patients with a history of seizures or those prone to seizures, those taking other medications with similar actions, those expected to have changes in urine acidity, and patients with heart disease or uncontrolled hypertension. Taking this medication may cause side effects such as dizziness, headache, constipation, drowsiness, and hypertension, and in rare cases, symptoms like confusion, hallucinations, and seizures may also occur. When used with other medications, interactions may occur, so caution is especially required when combining it with NMDA antagonists, antipsychotic medications, skeletal muscle relaxants, and anticoagulants. Women who are pregnant or breastfeeding must consult a doctor before taking this medication, and pregnant women must decide cautiously as it may affect the fetus. Safety and efficacy regarding children under the age of 18 have not been sufficiently confirmed. In cases of overdose, severe symptoms such as coma, hallucinations, and seizures may occur, so immediate medical attention is required if this medication is overdosed. This medication is primarily used for patients with severe Alzheimer's disease, who generally have reduced capabilities for driving or operating machinery, so special care is needed during these activities. Finally, this medication should be kept out of reach of children, and transferring it to other containers should be avoided to maintain quality and safety.

Side effects

  • dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • confusion
  • hallucinations
  • psychotic reactions
Show 24 more
  • balance disorder
  • gait abnormalities
  • seizures
  • heart failure
  • venous thrombosis/thromboembolism
  • dyspnea
  • vomiting
  • pancreatitis
  • elevated liver function test results
  • hepatitis
  • fatigue
  • nonspecific fatigue
  • weakness
  • diarrhea
  • anxiety
  • aggression
  • stupor
  • unconsciousness
  • restlessness
  • psychosis
  • visual hallucinations
  • convulsions
  • coma
  • double vision

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air and moisture, and it is best to store it at room temperature between 1 degree and 30 degrees Celsius. Storing it this way helps to maintain the medication's effectiveness and prevents deterioration.

Appearance and packaging

Appearance

White oval film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.